Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions
Endometriosis
Trial Locations (10)

70300

Yitzhak Shamir Medical Center /ID# 224768, Ẕerifin

91120

Hadassah Medical Center-Hebrew University /ID# 224769, Jerusalem

3515210

Clalit Health Services /ID# 224771, Haifa

4428164

Meir Medical Center /ID# 224766, Kfar Saba

5265601

The Chaim Sheba Medical Center /ID# 224764, Ramat Gan

6423906

Tel Aviv Sourasky Medical Center /ID# 224765, Tel Aviv

6789140

Maccabi Health Services /ID# 224775, Tel Aviv

7660101

Kaplan Medical Center /ID# 224773, Rehovot

7747629

Assuta Ashdod Medical Center /ID# 244898, Ashdod

8410101

Soroka University Medical Center /ID# 224774, Beersheba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY